Minimal Residual Disease Status in Acute Myeloid Leukemia Patients Undergoing T-Cell Replete Haploidentical Transplantation. an Analysis From the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (Ebmt)

Authors :: Jonathan Canaani
Arnon Nagler
Myriam Labopin
Stella Santarone
Mohamad Mohty
Depei Wu
Xiao-Jun Huang
Maria Teresa Van Lint
Fabio Ciceri
Didier Blaise
Simona Sica
José Luis Díez-Martín
Benedetto Bruno
Source :: Biology of Blood and Marrow Transplantation. 24:S106-S107
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
Transplantation
medicine.medical_specialty
Acute leukemia
Haploidentical transplantation
business.industry
Marrow transplantation
T cell replete
Myeloid leukemia
Hematology
Minimal residual disease
Internal medicine
medicine
business

Tools